macular edema


Also found in: Dictionary, Thesaurus, Wikipedia.
Related to macular edema: Diabetic macular edema

macular edema

Ophthalmology Waxing and waning retinal thickening due to the accumulation of fluid, seen in Pts with diabetic retinopathy, seen with a binocular slit lamp or stereoscopic fundus photography; while ME has no visual consequences, it is often accompanied by hard exudates, which are associated with loss of vision. See Diabetic retinopathy, Hard exudate.
References in periodicals archive ?
Vasoactive and inflammatory mediators cause capillary leakage, which may form the basis for macular edema and breakdown of the aqueous blood barrier, resulting in anterior uveitis and periphlebitis.
ILUVIEN is a unique product that addresses a clear unmet need for patients suffering from diabetic macular edema, and we are very excited about the prospect of making it available to Canadian patients.
The FDA previously had approved Lucentis to treat DME and macular edema secondary to retinal vein occlusions, both of which cause fluid to leak into the macula resulting in blurred vision.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Devise corrective measures for pipeline projects by understanding Macular Edema pipeline depth and focus of Indication therapeutics.
VIBRANT was a Phase 3, randomized, double-masked, active-controlled 52-week study, comparing aflibercept solution for injection 2 milligram (mg) monthly with laser photocoagulation in subjects with macular edema secondary to BRVO.
About Diabetic Retinopathy with Diabetic Macular Edema (DME) Diabetic retinopathy is a common complication of diabetes, causing damage to the retina, which may lead to poor vision and vision loss.
The Company's lead program, AKB9778, is a firstinclass stabilizer of the Tie2 pathway and is in clinical development for diabetic macular edema.
7 mg intravitreal implant (Ozurdex, Allergan) under the marketing authorization extension is indicated for adult patients with visual impairment due to diabetic macular edema who are pseudophakic, or who were unable to undertake noncorticosteroid therapy.
The proceeds will support ongoing development of Aerpio's pipeline, including AKB-9778, which is entering Phase 1b/2a for the treatment of diabetic macular edema (DME).
EU approval is based on positive data from the Phase 3 VIBRANT study in patients with visual impairment due to macular edema secondary to BRVO.
Bayer HealthCare announced today that EYLEAA (aflibercept solution for injection into the eye) has been approved by the European Commission for the treatment of visual impairment due to diabetic macular edema (DME).

Full browser ?